Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain
暂无分享,去创建一个
C. Campbell | R. Vandrey | C. Mun | T. Speed | A. Huhn | K. Dunn | Katrina R. Hamilton | Cecilia L. Bergeria | Chung Jung Mun | Katrina R Hamilton | Cecilia L Bergeria | Traci J Speed | Ryan Vandrey
[1] B. Betz-Stablein,et al. Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies , 2022, Neuropsychopharmacology.
[2] S. Bierma-Zeinstra,et al. Incidence and Prevalence of Knee Osteoarthritis Using Codified and Narrative Data From Electronic Health Records: A Population‐Based Study , 2022, Arthritis care & research.
[3] G. Guyatt,et al. Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies , 2021, BMJ Open.
[4] C. Campbell,et al. Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model , 2021, Neuropsychopharmacology.
[5] B. Unver,et al. Reliability and minimal detectable change of the 2-minute walk test and Timed Up and Go test in patients with total hip arthroplasty , 2020, Hip international : the journal of clinical and experimental research on hip pathology and therapy.
[6] C. Campbell,et al. Cannabinoid effects on responses to quantitative sensory testing among individuals with and without clinical pain: a systematic review. , 2019, Pain.
[7] L. Fanucchi,et al. Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humans , 2019, Psychopharmacology.
[8] G. Bedi,et al. Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability , 2018, Neuropsychopharmacology.
[9] Z. Cooper,et al. Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective , 2018, Neuropsychopharmacology.
[10] M. Elsohly,et al. Effects of Cannabidiol on Morphine Conditioned Place Preference in Mice , 2017, Planta Medica.
[11] B. Betz-Stablein,et al. Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis , 2017, Neuropsychopharmacology.
[12] G. Bigelow,et al. Non-smoker exposure to secondhand cannabis smoke II: Effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects. , 2015, Drug and alcohol dependence.
[13] C. Terwee,et al. Measurement properties of performance-based measures to assess physical function in hip and knee osteoarthritis: a systematic review. , 2012, Osteoarthritis and cartilage.
[14] R. Hinman,et al. Measures of physical performance assessments: Self‐Paced Walk Test (SPWT), Stair Climb Test (SCT), Six‐Minute Walk Test (6MWT), Chair Stand Test (CST), Timed Up & Go (TUG), Sock Test, Lift and Carry Test (LCT), and Car Task , 2011, Arthritis care & research.
[15] L B Mokkink,et al. Performance-based methods for measuring the physical function of patients with osteoarthritis of the hip or knee: a systematic review of measurement properties. , 2006, Rheumatology.
[16] John D. Roberts,et al. Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine. , 2006, European journal of pharmacology.
[17] M. Stitzer,et al. Opioid abuse and cognitive performance. , 2005, Drug and alcohol dependence.
[18] M. Rowbotham,et al. A new human experimental pain model: the heat/capsaicin sensitization model. , 1999, Neuroreport.
[19] S. Braver,et al. The measurement of clinical pain intensity: a comparison of six methods , 1986, Pain.
[20] J. Kellgren,et al. Radiological Assessment of Osteo-Arthrosis , 1957, Annals of the rheumatic diseases.